For a list of the specific Surface devices that support DFCI, see Manage DFCI on Surface devices. DFCI integration flow. Let's look at the process of DFCI integration. DFCI integration, registration, enrollment, and management flow. First, the PC UEFI (BIOS) integrates the DFCI code and includes the Device Management Trust certificate.Afterwards, she was awarded a fellowship from the Harvard Society of Fellows. From 2007 until 2010, she was an Assistant Professor in the Computational Biology Program at Memorial Sloan-Kettering Cancer Center. Dr. Michor is the director of the Dana-Farber Cancer Institute Center for Cancer Evolution.Attention! Your ePaper is waiting for publication! By publishing your document, the content will be optimally indexed by Google via AI and sorted into the right category for over 500 million ePaper readers on YUMPU.The human ORFeome collection is made possible through support from the High-Tech Fund of the Dana-Farber Cancer Institute, The Ellison Foundation (Boston, MA), and by grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medical Sciences.Figure 3 Screenshot Command: cctk.exe -h --InternalSpeaker. We have now made the comparison with DFCI. Except for the partial ability to change the UEFI, CCTK is more fine-tunable than DFCI. A ...Acknowledgments. CCSB interactome mapping and ORFeome cloning efforts are supported by federal grants from the National Human Genome Research Institute, the National Cancer Institute and the National Science Foundation, and by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation.We are building out our Intune AutoPilot builds and wondering if HP is implementing or planning to enable/allow MS's DCFI model for direct config of Bios? I believe the plan is to support modern management natively. However whether that will be DFCI or something else is behind the scenes, and currently undefined.The human ORFeome collection is made possible through support from the High-Tech Fund of the Dana-Farber Cancer Institute, The Ellison Foundation (Boston, MA), and by grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medical Sciences. Acknowledgments. CCSB interactome mapping and ORFeome cloning efforts are supported by federal grants from the National Human Genome Research Institute, the National Cancer Institute and the National Science Foundation, and by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation.At Dana-Farber Cancer Institute's Ocular Melanoma Center, patients are cared for by a multidisciplinary team with expertise in ocular melanoma, including ophthalmologists, medical oncologists, radiation oncologists, and interventional radiologists who collaborate to deliver a personalized treatment plan for each patient.BayesMendel Lab. The BayesMendel lab dedicated to methodologies, models, software and implementation of prediction related to cancer susceptibility genes. Beginning with BRCAPRO in 1997, our prediction algorithms have been used clinically for about 25 years.The human ORFeome version 5.1 (hORFeome v5.1) collection, includes the previous human ORFeome releases (v1.1 and 3.1), with the addition of 3,272 newly transferred ORFs from MGC templates. h ORFeome v5.1 represents a central resource of cloned human ORFs which can be transferred easily to Gateway compatible destination vectors for various ... See a list of all the DFCI profile settings and their descriptions on Windows 10/11 client devices. Use these settings in a configuration profile to control UEFI firmware layer features using Microsoft Intune policy. You can manage the CPU, built-in hardware, and boot options on Windows 10/11 client devices using Microsoft Intune.People. Dr. Shiaulou Yuan is an Assistant Professor of Medicine at Massachusetts General Hospital and Harvard Medical School. Dr. Yuan received his undergraduate degree in molecular cell biology from University of California, Berkeley in 2004 under Dr. Athanasios Theologis. He completed his Ph.D. in genetics from Yale University in 2011 with Dr ...Apr 26, 2018 · Dana-Farber's Ann Gross, PhD, RN, Senior Vice President and Chief Nursing Officer, discusses the evolving role of nursing within oncology and keeping up with cancer advances and technology. Read more in the Boston Globe ( Dec 8, 2021 · Patients at Mass. General and Brigham and Women's and their community hospitals and physician groups as well as patients at Mass. Eye and Ear and Dana-Farber are eligible to share in an $18.4-million class-action settlement of a claim involving information the health-care providers' Web site may have shared with Facebook and Google - but they have to sign up by Dec. 15. Read more. Natasha M. Archer, MD. Pediatric Hematology/Oncology. No Ratings Available - Why Not?CCSB Interactome Mapping and ORFeome cloning efforts are supported by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation and by federal grants from the National Human Genome Research Institute and the National Cancer Institute of the National Institutes of Health, the National Science Foundation, and the US Department of Energy.CCSB-YI1. interactions from CCSB-YI11 1,809 interactions among 1,278 proteins. Yu et al Science 2008. Ito-core. interactions from Ito-Core 843 interactions among 813 proteins. Ito et al PNAS 2001. Uetz-screen. interactions from Uetz-screen 691 interactions among 437 proteins. Uetz et al Nature 2000.1984 - Dana-Farber Cancer Institute establishes the Molecular Biology Core Facilities (MBCF) to supply state of the art molecular biology tools to Institute researchers. 1991 - Dana-Farber investigators help introduce the use of naturally occurring growth hormones following high-dose chemotherapy, making bone marrow transplantation safer and ...Accounts of the complex cellular networks that underlie plant-specific functions are missing. We describe a proteome-wide binary protein-protein interaction map for the interactome network of the plant Arabidopsis thaliana containing ~6,200 highly reliable interactions between ~2,700 proteins. Community analyses of the resulting network shows ...The human ORFeome collection is made possible through support from the High-Tech Fund of the Dana-Farber Cancer Institute, The Ellison Foundation (Boston, MA), and by grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medical Sciences.Fighting cancer through data science. Powering the Dana-Farber cancer research engine to better understand cancer biology, therapies and prevention. This approach correctly predicts a functional category for 72% of the 1,393 characterized proteins with at least one partner of known function, and has been applied to predict functions for 364 previously uncharacterized proteins. A global analysis of 2,709 published interactions between proteins of the yeast Saccharomyces cerevisiae has been performed, enabling the establishment of a single ...CCSB interactome mapping and ORFeome cloning efforts are supported by federal grants from the National Human Genome Research Institute, the National Cancer Institute and the National Science Foundation, and by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation. For a list of the specific Surface devices that support DFCI, see Manage DFCI on Surface devices. DFCI integration flow. Let's look at the process of DFCI integration. DFCI integration, registration, enrollment, and management flow. First, the PC UEFI (BIOS) integrates the DFCI code and includes the Device Management Trust certificate.CCSB interactome mapping and ORFeome cloning efforts are supported by federal grants from the National Human Genome Research Institute, the National Cancer Institute and the National Science Foundation, and by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation. Kornelia Polyak, MD, PhD, is a Professor of Medicine at Harvard Medical School and in the Department of Medical Oncology at the Dana-Farber Cancer Institute. Dr. Polyak is a physician-scientist involved in biomedical research directed towards patient care. Research in her laboratory is dedicated to the molecular analysis of human breast cancer. Principal investigator Baochun Zhang, MB, PhD Assistant Professor of Medicine, Harvard Medical School Division of Hematologic Neoplasia Department of Medical Oncology Department of Cancer Immunology and Virology Dana-Farber Cancer Institute Office location: Mayer 521A Mail address: 450 Brookline Avenue, Mayer 521A, Boston, MA 02215 [email protected] Office phone: Variable / Field Name,Form Name,Section Header,Field Type,Field Label,"Choices, Calculations, OR Slider Labels",Field Note,Text Validation Type OR Show Slider Number,Text Validati liulab.dfci.harvard.eduThe isoform project is made possible through support from the High-Tech Fund of the Dana-Farber Cancer Institute, The Ellison Foundation (Boston, MA), and by grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medical Sciences.People & Contacts. Adam Bass. [email protected]. Adam Bass is an Associate Professor of medicine at Harvard Medical School, a physician/scientist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital and also is an associate member of the Broad Institute. Dr. The human ORFeome collection is made possible through support from the High-Tech Fund of the Dana-Farber Cancer Institute, The Ellison Foundation (Boston, MA), and by grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medical Sciences. We present a new version of the human ORFeome, human ORFeome 8.1 containing clonally-derived and sequence-confirmed ORFs as a set of Gateway Entry clones ready for transfer to Gateway-compatible expression vectors. W ith the Mammalian Gene Collection (MGC) resource as our original starting point, we obtained 12,230 clonal isolates, representing ... Kornelia Polyak, MD, PhD, is a Professor of Medicine at Harvard Medical School and in the Department of Medical Oncology at the Dana-Farber Cancer Institute. Dr. Polyak is a physician-scientist involved in biomedical research directed towards patient care. Research in her laboratory is dedicated to the molecular analysis of human breast cancer. The Breast Cancer Advocacy Group (BCAG) contributes an informed patient voice to breast cancer research. The advocates collaborate with breast cancer investigators within and beyond DF/HCC in planning and reviewing translational and clinical research in all its stages, with the goal of finding better treatments, improving patient outcomes, and ...Frontline Support provides advanced technical support to DFCI faculty and staff, distinct and in addition to the Partners Service Desk (Help Desk). Included in our support domain are non-standard equipment and configurations that are part of the diversity of tools and configurations critical to successful research work.BayesMendel Lab. The BayesMendel lab dedicated to methodologies, models, software and implementation of prediction related to cancer susceptibility genes. Beginning with BRCAPRO in 1997, our prediction algorithms have been used clinically for about 25 years. The human ORFeome version 5.1 (hORFeome v5.1) collection, includes the previous human ORFeome releases (v1.1 and 3.1), with the addition of 3,272 newly transferred ORFs from MGC templates. h ORFeome v5.1 represents a central resource of cloned human ORFs which can be transferred easily to Gateway compatible destination vectors for various ... Acknowledgments. CCSB interactome mapping and ORFeome cloning efforts are supported by federal grants from the National Human Genome Research Institute, the National Cancer Institute and the National Science Foundation, and by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation.People & Contacts. Adam Bass. [email protected]. Adam Bass is an Associate Professor of medicine at Harvard Medical School, a physician/scientist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital and also is an associate member of the Broad Institute. Dr. Natasha M. Archer, MD. Pediatric Hematology/Oncology. No Ratings Available - Why Not?The PREMM 5 model is a clinical prediction algorithm that estimates the cumulative probability of an individual carrying a germline mutation in the MLH1, MSH2, MSH6, PMS2, or EPCAM genes. Mutations in these genes cause Lynch syndrome, an inherited cancer predisposition syndrome. In addition to information about the individual being evaluated ...Patients at Mass. General and Brigham and Women's and their community hospitals and physician groups as well as patients at Mass. Eye and Ear and Dana-Farber are eligible to share in an $18.4-million class-action settlement of a claim involving information the health-care providers' Web site may have shared with Facebook and Google - but they have to sign up by Dec. 15. Read more.network name description non-loop nodes count non-loop edges count loop-only nodes count loop edges count; WI-2007: interactions from 2007 Y2H screen: 1465Acknowledgments. CCSB interactome mapping and ORFeome cloning efforts are supported by federal grants from the National Human Genome Research Institute, the National Cancer Institute and the National Science Foundation, and by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation.The human ORFeome collection is made possible through support from the High-Tech Fund of the Dana-Farber Cancer Institute, The Ellison Foundation (Boston, MA), and by grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medical Sciences. BayesMendel Lab. The BayesMendel lab dedicated to methodologies, models, software and implementation of prediction related to cancer susceptibility genes. Beginning with BRCAPRO in 1997, our prediction algorithms have been used clinically for about 25 years. The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community. The primary goal of the Cancer Center is to ...Harvard UniversityOur People. The Department of Data Science is a vibrant academic research department with over 250 faculty, research scientists, postdoctoral fellows, staff and students.With a career at Dana-Farber Cancer Institute, you can play an important role in helping to fulfill our mission and ultimate goal: the eradication of cancer and related diseases.Our People. The Department of Data Science is a vibrant academic research department with over 250 faculty, research scientists, postdoctoral fellows, staff and students.CCSB-YI1. interactions from CCSB-YI11 1,809 interactions among 1,278 proteins. Yu et al Science 2008. Ito-core. interactions from Ito-Core 843 interactions among 813 proteins. Ito et al PNAS 2001. Uetz-screen. interactions from Uetz-screen 691 interactions among 437 proteins. Uetz et al Nature 2000.People & Contacts. Adam Bass. [email protected]. Adam Bass is an Associate Professor of medicine at Harvard Medical School, a physician/scientist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital and also is an associate member of the Broad Institute. Dr. The Dana–Farber/Harvard Cancer Center is the largest National Cancer Institute (NCI) designated Comprehensive Cancer Center in the nation. Founded in 1997, DF/HCC is an inter-institutional research enterprise that unites all of the cancer research efforts of the Harvard affiliated community. The primary goal of the Cancer Center is to ...Onsite: Full time on Campus. Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care. We are united in our mission of conquering cancer, HIV/AIDS and related diseases. We strive to create an inclusive, diverse, and equitable environment where ...Here we present a fourth version of the human ORFeome, human ORFeome 7.1. W ith the Mammalian Gene Collection (MGC) resource as a starting point, we successfully cloned 18,414 human ORFs, representing at least 15,415 human genes, as mini-pools of PCR-amplified products. The human ORFeome version 7.1 (hORFeome v7.1) collection, includes the ...Dana-Farber Cancer Institute. Mass General Brigham. English Eng English Eng; Ver en Español Посмотреть ...People & Contacts. Adam Bass. [email protected]. Adam Bass is an Associate Professor of medicine at Harvard Medical School, a physician/scientist at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital and also is an associate member of the Broad Institute. Dr. Here we present a fourth version of the human ORFeome, human ORFeome 7.1. W ith the Mammalian Gene Collection (MGC) resource as a starting point, we successfully cloned 18,414 human ORFs, representing at least 15,415 human genes, as mini-pools of PCR-amplified products. The human ORFeome version 7.1 (hORFeome v7.1) collection, includes the ...Our People. The Department of Data Science is a vibrant academic research department with over 250 faculty, research scientists, postdoctoral fellows, staff and students.The human ORFeome collection is made possible through support from the High-Tech Fund of the Dana-Farber Cancer Institute, The Ellison Foundation (Boston, MA), and by grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medical Sciences. DFCI's Communications Department offers a Lab Website Program (LWP) at no cost, utilizing DFCI branded templates designed for non-technical professionals to learn and use. Contact to get started: Luise Dittrich - Project Manager, LWP.Dana-Farber Cancer Institute. Mass General Brigham. English Eng English Eng; Ver en Español Посмотреть ... CCSB-YI1. interactions from CCSB-YI11 1,809 interactions among 1,278 proteins. Yu et al Science 2008. Ito-core. interactions from Ito-Core 843 interactions among 813 proteins. Ito et al PNAS 2001. Uetz-screen. interactions from Uetz-screen 691 interactions among 437 proteins. Uetz et al Nature 2000. Harvard UniversityThe isoform project is made possible through support from the High-Tech Fund of the Dana-Farber Cancer Institute, The Ellison Foundation (Boston, MA), and by grants from the National Cancer Institute, the National Human Genome Research Institute, and the National Institute of General Medical Sciences. liulab.dfci.harvard.eduDFCI enables Windows to pass management commands from Intune to UEFI (Unified Extensible Firmware Interface). In Intune, use this feature to control BIOS settings. Typically, firmware is more resilient to malicious attacks. It limits end users control over the BIOS, which is good in a compromised situation.Variable / Field Name,Form Name,Section Header,Field Type,Field Label,"Choices, Calculations, OR Slider Labels",Field Note,Text Validation Type OR Show Slider Number,Text ValidatiWe are building out our Intune AutoPilot builds and wondering if HP is implementing or planning to enable/allow MS's DCFI model for direct config of Bios? I believe the plan is to support modern management natively. However whether that will be DFCI or something else is behind the scenes, and currently undefined.Microsoft DFCI Scenarios¶ Overview¶ Microsoft leverages DFCI to provide automated UEFI settings management via Microsoft Intune. Intune provides the IT manager with abstracted, easy button settings that are generally applicable to all platforms, for example, disable booting USB devices or disable all cameras. May 1, 2005 · In a November 2004 Boston Globe retrospective on the Lehman and Bateman overdoses, reporter Scott Allen described the Dana-Farber as "one of the most safety-conscious hospitals in America." In fact, we reported to the Globe 8 years of data from our confidential incident reporting system. Although it showed rare errors, there were no deaths or serious injuries from chemotherapy-related errors ... Through our 12 specialized disease treatment centers, experts from our two organizations, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, work together as one team to offer the most advanced treatments with compassion and care that makes all the difference. For over 20 years, US News & World Report has named Dana-Farber Brigham ...May 1, 2005 · In a November 2004 Boston Globe retrospective on the Lehman and Bateman overdoses, reporter Scott Allen described the Dana-Farber as "one of the most safety-conscious hospitals in America." In fact, we reported to the Globe 8 years of data from our confidential incident reporting system. Although it showed rare errors, there were no deaths or serious injuries from chemotherapy-related errors ... Move the mouse over the map and this page will show you the Maidenhead locator, latitude/longitude coordinates in WGS84 (both decimal and DMS), UTM as well as french Lambert II and DFCI. You can zoom the map with the help of the mouse wheel or the control on the upper left part of the map. Please remember to access using Cisco AnyConnect VPN or be on the Dana-Farber network (PHSwifi3 or wired ethernet). Graphpad Prism software licenses Friday, February 17, 2023 - 2:44pmDana-Farber Cancer Institute is part of a Comprehensive Cancer Center designated by the National Cancer Institute. It is a major affiliate of Harvard Medical School and is located in the Longwood Medical Area in Boston, Massachusetts. The origins of Dana-Farber date back to 1947 when Sidney Farber, MD, founded Children's Cancer Research ... Harvard UniversityAt Dana-Farber Cancer Institute's Ocular Melanoma Center, patients are cared for by a multidisciplinary team with expertise in ocular melanoma, including ophthalmologists, medical oncologists, radiation oncologists, and interventional radiologists who collaborate to deliver a personalized treatment plan for each patient.Michor is the director of the Dana-Farber Cancer Institute Center for Cancer Evolution. She has been the recipient of the Theodosius Dobzhansky Prize of the Society for the Study of Evolution, the Alice Hamilton Award, the Vilcek Prize for Creative Promise in Biomedical Science, the 36th Annual AACR Award for Outstanding Achievement in Cancer ... Harvard UniversityNatasha M. Archer, MD. Pediatric Hematology/Oncology. No Ratings Available - Why Not? Submitting new studies and managing ongoing studies in treatment-based (clinical) research.dfcionline.orgPrincipal investigator Baochun Zhang, MB, PhD Assistant Professor of Medicine, Harvard Medical School Division of Hematologic Neoplasia Department of Medical Oncology Department of Cancer Immunology and Virology Dana-Farber Cancer Institute Office location: Mayer 521A Mail address: 450 Brookline Avenue, Mayer 521A, Boston, MA 02215 [email protected] Office phone: Variable / Field Name,Form Name,Section Header,Field Type,Field Label,"Choices, Calculations, OR Slider Labels",Field Note,Text Validation Type OR Show Slider Number,Text Validati
Electronic data capture and tracking: Manage, clean, store, and retrieve clinical trials data; create electronic case report forms. Users: Clinical researchers, Research staff. Institutions: DF/HCC, Outside participating sites. Access and support: IS Service Hub instructions.. Famous children
Harvard UniversityCCSB-YI1. interactions from CCSB-YI11 1,809 interactions among 1,278 proteins. Yu et al Science 2008. Ito-core. interactions from Ito-Core 843 interactions among 813 proteins. Ito et al PNAS 2001. Uetz-screen. interactions from Uetz-screen 691 interactions among 437 proteins. Uetz et al Nature 2000.CCSB interactome mapping and ORFeome cloning efforts are supported by federal grants from the National Human Genome Research Institute, the National Cancer Institute and the National Science Foundation, and by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation. At Dana-Farber Cancer Institute's Ocular Melanoma Center, patients are cared for by a multidisciplinary team with expertise in ocular melanoma, including ophthalmologists, medical oncologists, radiation oncologists, and interventional radiologists who collaborate to deliver a personalized treatment plan for each patient.Windows 10 With Windows Autopilot Deployment and Intune, you can manage Unified Extensible Firmware Interface (UEFI) settings after they're enrolled by using the Device Firmware Configuration Interface (DFCI). DFCI enables Windows to pass management commands from Intune to UEFI for Autopilot deployed devices.Myles Brown, MD, is a Professor of Medicine at DFCI and HMS as well as a practicing physician in oncology at the Brigham And Women's Hospital.Dr. Brown's research laboratory focuses on elucidating the epigenetic factors underlying the action of steroid hormones. Jul 19, 2023 · The Michor lab is interested in cancer evolution through the use of integrative data science, experimental, clinical, and population science approaches. We develop methodology to develop, analyze, and integrate diverse data types and design predictive algorithms using approaches from applied mathematics, statistics, bioinformatics, and machine ... Afterwards, she was awarded a fellowship from the Harvard Society of Fellows. From 2007 until 2010, she was an Assistant Professor in the Computational Biology Program at Memorial Sloan-Kettering Cancer Center. Dr. Michor is the director of the Dana-Farber Cancer Institute Center for Cancer Evolution.CCSB interactome mapping and ORFeome cloning efforts are supported by federal grants from the National Human Genome Research Institute, the National Cancer Institute and the National Science Foundation, and by funding from the Dana-Farber Cancer Institute Strategic Initiative, The Ellison Foundation and the W. M. Keck Foundation.Unlike many medical schools, HMS does not own or operate hospitals, relying instead on agreements with 15 clinical affiliates and research institutes, vital partners that provide patient care and clinical training. These hospitals and institutes employ many physicians and scientists with Harvard Medical School faculty appointments. All told ...The human ORFeome version 5.1 (hORFeome v5.1) collection, includes the previous human ORFeome releases (v1.1 and 3.1), with the addition of 3,272 newly transferred ORFs from MGC templates. h ORFeome v5.1 represents a central resource of cloned human ORFs which can be transferred easily to Gateway compatible destination vectors for various ...Fighting cancer through data science. Powering the Dana-Farber cancer research engine to better understand cancer biology, therapies and prevention.Professor of Neurology, Brigham and Women's Hospital and Harvard Medical School. Departments and Centers. Department of Cancer Immunology and Virology. About the Department. Our Team. Basic Immunological Mechanisms. Cancer Immunology and Immunotherapy. Cancer Immunology Working Group. Viral Immunology.Robert and Renée Belfer’s transformative cumulative Dana-Farber investment of more than $25 million launched the Robert A. and Renée E. Belfer Center for Applied Cancer Science. Their generosity enabled the Belfer Center to integrate its scientific teams, produce innovative cancer models, partner with industry leaders, and accelerate the ...Natasha M. Archer, MD. Pediatric Hematology/Oncology. No Ratings Available - Why Not?We present a new version of the human ORFeome, human ORFeome 8.1 containing clonally-derived and sequence-confirmed ORFs as a set of Gateway Entry clones ready for transfer to Gateway-compatible expression vectors. W ith the Mammalian Gene Collection (MGC) resource as our original starting point, we obtained 12,230 clonal isolates, representing ....